IC
FNCH
Ikarian Capital’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,892
| Closed | -$18.1K | – | 115 |
|
|
2024
Q1 | $18.1K | Hold |
6,892
| – | – | ﹤0.01% | 79 |
|
|
2023
Q4 | $24.9K | Hold |
6,892
| – | – | ﹤0.01% | 74 |
|
|
2023
Q3 | $35.1K | Sell |
6,892
-1,025
| -13% | -$5.23K | ﹤0.01% | 76 |
|
|
2023
Q2 | $67.5K | Sell |
7,917
-229,636
| -97% | -$1.96M | 0.01% | 78 |
|
|
2023
Q1 | $93.4K | Hold |
237,553
| – | – | 0.02% | 86 |
|
|
2022
Q4 | $114K | Hold |
237,553
| – | – | 0.03% | 61 |
|
|
2022
Q3 | $397K | Sell |
237,553
-92,970
| -28% | -$155K | 0.08% | 52 |
|
|
2022
Q2 | $938K | Hold |
330,523
| – | – | 0.17% | 47 |
|
|
2022
Q1 | $1.66M | Buy |
330,523
+14,791
| +5% | +$74.4K | 0.22% | 47 |
|
|
2021
Q4 | $3.15M | Hold |
315,732
| – | – | 0.47% | 28 |
|
|
2021
Q3 | $4.11M | Sell |
315,732
-9,268
| -3% | -$121K | 0.29% | 31 |
|
|
2021
Q2 | $4.57M | Buy |
325,000
+175,000
| +117% | +$2.46M | 0.37% | 34 |
|
|
2021
Q1 | $2.39M | Buy |
+150,000
| New | +$2.39M | 0.08% | 94 |
|